Regulation & law · 24/02/2020Updated: 10/17/2026 · 1 min read

DEA Receives Application from Irvine Labs, Inc. for Bulk Registration of Controlled Substances

The Drug Enforcement Administration (DEA) has announced that it has received an application from Irvine Labs, Inc. to manufacture in bulk basic classes of controlled substances listed in Schedule I, and plans to establish regulations for growing marihuana for scientific and medical research purposes under DEA registration.